Multinationals rush to snap up Chinese biotech assets amid drug licensing boom

Multinationals rush to snap up Chinese biotech assets amid drug licensing boom

Photo by Raimond Klavins on Unsplash

Stephanie Li

28 July, 2025

Edited by: Pramod Mathew

big pharmabiotechout-licensing

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.